Skip to main content

Table 2 Patient characteristics (N = 67)

From: Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy

Age, years, median (range)

79 (60–92)

Sex

Male

n = 24 (36 %)

 

Female

n = 43 (64 %)

Stage

IA

n = 52 (78 %)

 

IB-III

n = 15 (22 %)

Location

Left Lower lobe

n = 16 (24 %)

Left Upper Lobe

n = 16 (24 %)

Right Lower Lobe

n = 12 (18 %)

Right Upper Lobe

n = 23 (34 %)

Tumor volume

<2.5 cc

n = 17 (25 %)

5-2.5 cc

n = 19 (29 %)

5-10 cc

n = 7 (11 %)

10-20 cc

n = 9 (13 %)

>20 cc

n = 15 (22 %)

BED10 a

Mean

107.8

 

Median (Range)

105.6 (180–85.5)

Tracking

XSight-spine

n = 30 (45 %)

 

XSight-lung

n = 3 (5 %)

 

XSight-spine + Fiducials

n = 34 (50 %)

Histology

Adenocarcinoma

n = 30 (44 %)

 

Squamous Cell Carcinoma

n = 14 (21 %)

 

Non-small cell lung carcinoma-NOSb

n = 14 (21 %)

 

Carcinoid

n = 3 (4 %)

 

Sarcomatoid mesothelioma

n = 1 (2 %)

 

Non-diagnostic biopsy

n = 6 (8 %)

  1. aBiologic Effective Dose, Gy10 or α/β ratio = 10
  2. bNot otherwise specified